
Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Description
Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global pain management drugs market size reached US$ 67.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 85.3 Billion by 2028, exhibiting a growth rate (CAGR) of 2.8% during 2023-2028.
Pain management drugs perform pharmacological actions on pain receptors and work against discomfort-causing symptoms. These medications provide relief from the distressing feeling caused due to various health issues, such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis and cancer, by acting through different physiological functions. In recent years, medical advancements have led to the introduction of novel combinations and newer drug delivery techniques that provide improved pain management.
One of the key factors driving the global market is the rising geriatric population across the globe. In 2018, the population of people aged 60 years and above was around 991 million. This population is projected to reach 1.18 billion by 2024. With the prevalence of chronic pain being significantly higher in older adults, the demand for pain management drugs is escalating across the globe. Furthermore, a rise in the number of hospitalization cases and a huge demand-supply gap for effective neuropathic pain management drugs have led to the emergence of innovative and advanced therapies and medicines. Moreover, the leading pharmaceutical companies are investing heavily in research and development (R&D) activities to develop analgesics or painkillers that are safer, more effective, economically viable and easier to administer. Other factors, including rising healthcare expenditure, improving R&D, increasing consumer awareness, and significant government support for improving healthcare services, are driving the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pain management drugs market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on drug class, indication and distribution channel.
Breakup by Drug Class:
NSAIDs
Anesthetics
Anticonvulsants
Antimigraine Agents
Antidepressants
Opioids
Others
Breakup by Indication:
Musculoskeletal Pain
Surgical and Trauma Pain
Cancer Pain
Neuropathic Pain
Migraine Pain
Obstetrical Pain
Fibromyalgia Pain
Burn Pain
Dental/Facial Pain
Pediatric Pain
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the pain management drugs companies being Abbott Laboratories, Inc., Pfizer, Inc., Eli Lilly & Company, Endo International plc, F. Hoffmann-La Roche AG, Bausch Health Companies, Inc., Merck & Co. Inc., Allergen Inc., Novartis International AG, Johnson & Johnson Private Limited, GlaxoSmithKline Plc and Purdue Pharma L.P.
Key Questions Answered in This Report
1. What was the global pain management drugs market size in 2022?
2. How will the global pain management drugs market perform over the next five years 2023-2028?
3. What is the impact of COVID-19 on the global pain management drugs market?
4. What are the key global pain management drugs market drivers?
5. What are the major trends in the global pain management drugs market?
6. What is the leading drug class in the global pain management drugs market?
7. What is the major indication in the global pain management drugs market?
8. What is the global pain management drugs market breakup by distribution channel?
9. What are the major regions in the global pain management drugs market?
10. Who are the leading pain management drug manufacturers?
Table of Contents
147 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Pain Management Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Breakup by Drug Class
- 5.5 Market Breakup by Indication
- 5.6 Market Breakup by Distribution Channel
- 5.7 Market Breakup by Region
- 5.8 Market Forecast
- 6 Market Breakup by Drug Class
- 6.1 NSAIDs
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Anesthetics
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Anticonvulsants
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Antimigraine Agents
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Antidepressants
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Opioids
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Others
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 7 Market Breakup by Indication
- 7.1 Musculoskeletal Pain
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Surgical and Trauma Pain
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Cancer Pain
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Neuropathic Pain
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Migraine Pain
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Obstetrical Pain
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Fibromyalgia Pain
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
- 7.8 Burn Pain
- 7.8.1 Market Trends
- 7.8.2 Market Forecast
- 7.9 Dental/Facial Pain
- 7.9.1 Market Trends
- 7.9.2 Market Forecast
- 7.10 Pediatric Pain
- 7.10.1 Market Trends
- 7.10.2 Market Forecast
- 7.11 Others
- 7.11.1 Market Trends
- 7.11.2 Market Forecast
- 8 Market Breakup by Distribution Channel
- 8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Pharmacies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 9 Market Breakup by Region
- 9.1 North America
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Europe
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Asia Pacific
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Middle East and Africa
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Latin America
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
- 10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
- 11 Value Chain Analysis
- 12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
- 13 Price Analysis
- 13.1 Price Indicators
- 13.2 Price Structure
- 13.3 Margin Analysis
- 14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories, Inc.
- 14.3.2 Pfizer, Inc.
- 14.3.3 Eli Lilly & Company
- 14.3.4 Endo International plc
- 14.3.5 F. Hoffmann-La Roche AG
- 14.3.6 Bausch Health Companies, Inc.
- 14.3.7 Merck & Co. Inc.
- 14.3.8 Allergen Inc.
- 14.3.9 Novartis International AG
- 14.3.10 Johnson & Johnson Private Limited
- 14.3.11 GlaxoSmithKline Plc
- 14.3.12 Purdue Pharma L.P
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.